Found 241 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is C  [Clear All Filters]
1999
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.
A. Mariotto, Dally, L., Micheli, A., Canario, F., and Verdecchia, A., Cancer prevalence in Italian regions with local cancer registries, Tumori, vol. 85, pp. 400-7, 1999.
M. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santo, S. M., A Case-Control-Study of Risk Factors for Homophiles Influenza Type B Disease in Navajo Children, AM J Trop Med Hug, vol. 60, no. 2, pp. 263-266, 1999.
S. Schurman, Stablein, D. M., Perlman, S. A., and Warady, B. A., Center volume effects in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Nephrol, vol. 5, pp. 373-8, 1999.
G. R. Lerner, Warady, B., Sullivan, E. K., and , Chronic dialysis in children and adolescents. The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Pediatr Nephrol, vol. 13, pp. 404-17, 1999.
A. Vigano, Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., and Principi, N., Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection, J Pediatric, vol. 135, pp. 675-82, 1999.
T. Gonwa, Ahsan, N., Halloran, P., Stegal, M., Hardy, M., Metzgar, R., Shield, III, C., Rocher, L., Scandling, J., Sorensen, L., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W., Comparative trial of Prograf™ (tacrolimus) in combination with azathiprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofeitil after kidney transplantation, 1999.
M. B. Leonard, Sullivan, E. K., Jabs, K., and Feldman, H. I., Comparison of mortality risks of dialysis and renal transplantation in children: A report of the North American Pediatric Cooperative Study (NAPRTCS), 1999.
J. Copley, Staffeld, C., Lindberg, J., Baily, C., and Van Veldhuisen, P., The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity, 1999.
E. L. Wagner, Brock, K. L., and Carter, S. L., The Cord Blood Transplantation (COBLT) Study: An internet data system for the COBLT Study Cord Blood Banks, 1999.
2000
R. R. Sokol, Oden, N. L., Rosenberg, M. S., and Thomson, B. A., Cancer incidences in Europe related to mortalities, ethnohistoric, genetic, and geographic distances, Proceedings of the National Academy of Science, vol. 97, pp. 6067-72, 2000.
R. Simon, Desper, R., Papadimetriou, C., Peng, A., Alberts, D. S., Taetle, R., Trent, J. M., and Schäffer, A. A., Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis, Genes Chromosomes Cancer, vol. 28, pp. 106-120, 2000.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416, Oncology, vol. 14, pp. 13121315-16 1321-23, 2000.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical Trials Referral Resource. Current Clinical Trials for the Proteasome Inhibitor PS-341, Oncology, vol. 14, no. 11, pp. 1589-15901593-941597, 2000.
R. S. Kaplan, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials in prostate cancer, Oncology, vol. 14, pp. 399-400403-404, 2000.
T. Davis, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral source. Current clinical trials of the anti- CD20 monoclonal antibody rituximab, Oncology, vol. 14, pp. 14371440-1443, 2000.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck, Oncology, vol. 14, pp. 553-554559 561, 2000.
J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults, J Infec Dis, vol. 181, pp. 725-8, 2000.
J. Kurzberg, Wagner, E. L., Cairo, M. S., Carter, S. L., Kernan, N. A., Jensen, L., Gindy, L., Issitt, L., and Fraser, J. K., The Cord Blood Transplantation (COBLT) Study: The First Two Years of Recruitment and Collection by the COBLT Cord Blood Banks, in American Society for Blood and Marrow Transplantation Annual Meeting, Anaheim, CA, 2000.